Indinavir
Back to searchMolecule Structure
Scientific Name
Indinavir
Description of the Drug
Indinavir is a protease inhibitor used to treat HIV infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00224
http://www.drugbank.ca/drugs/DB00224
Brand Name(s)
Crixivan
Company Owner(s)
Merck Sharp And Dohme Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL6317 | |||
| PharmGKB | PA449977 | |||
| Human Metabolome Database | HMDB0014369 | |||
| DrugBank | DB00224 | |||
| PubChem: Thomson Pharma | 14862973 | 14765204 | ||
| PubChem | 5362440 | |||
| NMRShiftDB | 80014421 | |||
| LINCS | LSM-5471 | |||
| Nikkaji | J566.361J | |||
| PDBe | MK1 | |||
| BindingDB | 50067593 | 517 | ||
| EPA CompTox Dashboard | DTXSID4043802 | |||
| DrugCentral | 1437 | |||
| Brenda | 229531 | 1036 | 229532 | 66585 |
| ChemicalBook | CB6123497 | |||
| rxnorm | INDINAVIR ANHYDROUS | INDINAVIR SULFATE | INDINAVIR | CRIXIVAN |
| KEGG Ligand | C07051 | |||
| ChEBI | 44032 | |||
| ZINC | ZINC000022448696 |
